Massachusetts 194th General Court Status: Introduced 1 D cosponsors

S2035 — An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 194th General Court. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

In plain language

The bill removes the tax deduction for pharmaceutical companies' direct-to-consumer marketing expenses.

This legislation eliminates the ability for pharmaceutical companies to deduct expenses related to marketing their products directly to consumers from their taxes. This change aims to affect how pharmaceutical companies budget for marketing.

What this means for you
  • Consumers: Consumers might see different advertising strategies from pharmaceutical companies as they adjust to the removal of tax deductions.
  • Healthcare: This may lead to changes in how pharmaceutical companies promote their products to patients and healthcare providers.

Summary

An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

Bill Text

  • Full text Current

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 203 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (203)

203 members have not signed on to this bill.

Show all 203 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S2035 do?
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
Who sponsors S2035?
S2035 is sponsored by Jason M. Lewis (Democrat).
What is the current status of S2035?
This bill died with 194th General Court. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track S2035?
Track S2035 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S2035

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of S2035

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →